293 related articles for article (PubMed ID: 30408635)
1. Elevated coagulation factor levels affect the tissue factor-threshold in thrombin generation.
Rietveld IM; Schreuder M; Reitsma PH; Bos MHA
Thromb Res; 2018 Dec; 172():104-109. PubMed ID: 30408635
[TBL] [Abstract][Full Text] [Related]
2. Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II.
van 't Veer C; Mann KG
J Biol Chem; 1997 Feb; 272(7):4367-77. PubMed ID: 9020158
[TBL] [Abstract][Full Text] [Related]
3. Marked elevation of thrombin generation in patients with elevated FVIII:C and venous thromboembolism.
O'Donnell J; Mumford AD; Manning RA; Laffan MA
Br J Haematol; 2001 Dec; 115(3):687-91. PubMed ID: 11736955
[TBL] [Abstract][Full Text] [Related]
4. Elevated plasma factor VIII enhances venous thrombus formation in rabbits: contribution of factor XI, von Willebrand factor and tissue factor.
Sugita C; Yamashita A; Matsuura Y; Iwakiri T; Okuyama N; Matsuda S; Matsumoto T; Inoue O; Harada A; Kitazawa T; Hattori K; Shima M; Asada Y
Thromb Haemost; 2013 Jul; 110(1):62-75. PubMed ID: 23636277
[TBL] [Abstract][Full Text] [Related]
5. "Normal" thrombin generation.
Butenas S; van't Veer C; Mann KG
Blood; 1999 Oct; 94(7):2169-78. PubMed ID: 10498586
[TBL] [Abstract][Full Text] [Related]
6. Factor IX from prothrombin complex concentrate augments low dose tissue factor-triggered thrombin generation in vitro.
Hasan S; Abuelkasem E; Williams B; Henderson R; Mazzeffi MA; Tanaka KA
Br J Anaesth; 2018 Oct; 121(4):936-943. PubMed ID: 30236256
[TBL] [Abstract][Full Text] [Related]
7. Selective factor VIII activation by the tissue factor-factor VIIa-factor Xa complex.
Kamikubo Y; Mendolicchio GL; Zampolli A; Marchese P; Rothmeier AS; Orje JN; Gale AJ; Krishnaswamy S; Gruber A; Østergaard H; Petersen LC; Ruf W; Ruggeri ZM
Blood; 2017 Oct; 130(14):1661-1670. PubMed ID: 28729433
[TBL] [Abstract][Full Text] [Related]
8. The technique of measuring thrombin generation with fluorogenic substrates: 3. The effects of sample dilution.
De Smedt E; Wagenvoord R; Coen Hemker H
Thromb Haemost; 2009 Jan; 101(1):165-70. PubMed ID: 19132204
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the initiation phase of blood coagulation using ultrasensitive assays for serine proteases.
Butenas S; van 't Veer C; Mann KG
J Biol Chem; 1997 Aug; 272(34):21527-33. PubMed ID: 9261172
[TBL] [Abstract][Full Text] [Related]
10. Ex vivo thrombin generation in patients with venous thromboembolic disease or atrial fibrillation on long-term oral anticoagulation.
Musial J; Brzezinska-Kolarz B; Zólcinski M; Lelakowski J; Szczeklik A
Clin Appl Thromb Hemost; 2010 Dec; 16(6):614-21. PubMed ID: 20460350
[TBL] [Abstract][Full Text] [Related]
11. Circulating tissue factor procoagulant activity and thrombin generation in patients with type 2 diabetes: effects of insulin and glucose.
Boden G; Vaidyula VR; Homko C; Cheung P; Rao AK
J Clin Endocrinol Metab; 2007 Nov; 92(11):4352-8. PubMed ID: 17785358
[TBL] [Abstract][Full Text] [Related]
12. Tissue factor-dependent blood coagulation is enhanced following delivery irrespective of the mode of delivery.
Boer K; den Hollander IA; Meijers JC; Levi M
J Thromb Haemost; 2007 Dec; 5(12):2415-20. PubMed ID: 17883594
[TBL] [Abstract][Full Text] [Related]
13. Influence of single nucleotide polymorphisms on thrombin generation in factor V Leiden heterozygotes.
Segers O; Simioni P; Tormene D; Castoldi E
Thromb Haemost; 2014 Mar; 111(3):438-46. PubMed ID: 24226152
[TBL] [Abstract][Full Text] [Related]
14. Coagulant proteins and thrombin generation in synovial fluid: a model for extravascular coagulation.
Chang P; Aronson DL; Borenstein DG; Kessler CM
Am J Hematol; 1995 Oct; 50(2):79-83. PubMed ID: 7573004
[TBL] [Abstract][Full Text] [Related]
15. Effects of tissue factor, thrombomodulin and elevated clotting factor levels on thrombin generation in the calibrated automated thrombogram.
Machlus KR; Colby EA; Wu JR; Koch GG; Key NS; Wolberg AS
Thromb Haemost; 2009 Nov; 102(5):936-44. PubMed ID: 19888532
[TBL] [Abstract][Full Text] [Related]
16. Tissue factor over-expression by human pancreatic cancer cells BXPC3 is related to higher prothrombotic potential as compared to breast cancer cells MCF7.
Gerotziafas GT; Galea V; Mbemba E; Khaterchi A; Sassi M; Baccouche H; Prengel C; van Dreden P; Hatmi M; Bernaudin JF; Elalamy I
Thromb Res; 2012 Jun; 129(6):779-86. PubMed ID: 21917301
[TBL] [Abstract][Full Text] [Related]
17. Influence of coagulation factors and tissue factor concentration on the thrombin generation test in plasma.
Duchemin J; Pan-Petesch B; Arnaud B; Blouch MT; Abgrall JF
Thromb Haemost; 2008 Apr; 99(4):767-73. PubMed ID: 18392335
[TBL] [Abstract][Full Text] [Related]
18. Peak thrombin generation and subsequent venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE) study.
Lutsey PL; Folsom AR; Heckbert SR; Cushman M
J Thromb Haemost; 2009 Oct; 7(10):1639-48. PubMed ID: 19656279
[TBL] [Abstract][Full Text] [Related]
19. The role of procoagulants and anticoagulants in the development of venous thromboembolism.
Bertina RM
Thromb Res; 2009; 123 Suppl 4():S41-5. PubMed ID: 19303503
[TBL] [Abstract][Full Text] [Related]
20. Persistent high factor VIII activity leading to increased thrombin generation - a prospective cohort study.
Ryland JK; Lawrie AS; Mackie IJ; Machin SJ
Thromb Res; 2012 Apr; 129(4):447-52. PubMed ID: 21849206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
